FdaApplication
NDA 020837
Identifiers
- fda_app_no: NDA020837
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | NDA |
| approval_date | 1999-03-25 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION |
| XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.25% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION |
| XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION |
| XOPENEX | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INHALATION |
4 products